Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer()

The MIS pathway is a potential therapeutic target in epithelial ovarian cancer (EOC): signaling requires both type II (T2R) and type I receptors (T1R), and results in growth inhibition. MISR2 is expressed in EOC, but the prevalence and relative contributions of candidate T1R remain unknown. We sough...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Mol Med
Main Authors: Basal, E., Ayeni, T., Zhang, Q., Langstraat, C., Donahoe, P.K., Pepin, D., Yin, X., Leof, E., Cliby, W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4813308/
https://ncbi.nlm.nih.gov/pubmed/26917267
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados